Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

NSCLC biology and new therapies: Immunotherapies

Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain
NSCLC biology and new therapies: Immunotherapies ( Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain )
5 Oct 2016

NSCLC biology and new therapies: Animal models of lung cancer

Prof Julian Downward - The Francis Crick Institute, London, UK
NSCLC biology and new therapies: Animal models of lung cancer ( Prof Julian Downward - The Francis Crick Institute, London, UK )
5 Oct 2016

Screening, surgical cure and new developments: Q & A

Dr Henschke, Prof Field, Dr Pastorino, Dr Di Meco
Screening, surgical cure and new developments: Q & A ( Dr Henschke, Prof Field, Dr Pastorino, Dr Di Meco )
5 Oct 2016

Screening, surgical cure and new developments: Current state of the art surgery

Dr Ugo Pastorino - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Screening, surgical cure and new developments: Current state of the art surgery ( Dr Ugo Pastorino - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )
5 Oct 2016

Screening, surgical cure and new developments: How to organise a national screening programme

Prof John Field - University of Liverpool, Liverpool, UK
Screening, surgical cure and new developments: How to organise a national screening programme ( Prof John Field - University of Liverpool, Liverpool, UK )
5 Oct 2016

Screening, surgical cure and new developments: How to avoid false positives in lung cancer screening

Dr Claudia Henschke - Mount Sinai Hospital, New York, USA
Screening, surgical cure and new developments: How to avoid false positives in lung cancer screening ( Dr Claudia Henschke - Mount Sinai Hospital, New York, USA )
5 Oct 2016

Tumour heterogeneity and the impact on patient care

Dr Nicholas McGranahan - The Francis Crick Institute, London, UK
Tumour heterogeneity and the impact on patient care ( Dr Nicholas McGranahan - The Francis Crick Institute, London, UK )
5 Oct 2016

Immunotherapy in lung cancer: Q & A

Prof Giuseppe Giaccone and Dr Olivier Pardo
Immunotherapy in lung cancer: Q & A ( Prof Giuseppe Giaccone and Dr Olivier Pardo )
5 Oct 2016

Immunotherapy in SCLC

Prof Dean Fennell - University of Leicester, Leicester, UK
Immunotherapy in SCLC ( Prof Dean Fennell - University of Leicester, Leicester, UK )
5 Oct 2016

Immunotherapy in NSCLC

Prof Giuseppe Giaccone - Georgetown University, Washington DC, USA
Immunotherapy in NSCLC ( Prof Giuseppe Giaccone - Georgetown University, Washington DC, USA )
5 Oct 2016

Omics, early detection and novel therapies: Q & A

Dr Murrell and Dr Pardo
Omics, early detection and novel therapies: Q & A ( Dr Murrell and Dr Pardo )
5 Oct 2016

Omics, early detection and novel therapies: Metabolomics

Dr Olivier Pardo - Imperial College London, London, UK
Omics, early detection and novel therapies: Metabolomics ( Dr Olivier Pardo - Imperial College London, London, UK )
5 Oct 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation